Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Jan 17, 2020
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
This is randomized controlled trial to investigate if enalapril is superior to nifedipine in terms of medical resources used in postpartum women with hypertension. These are both antihypertensives we commonly use in the postpartum period for women with hypertension in pregnancy but we do not know which medication works better at decreasing prolonged hospitalizations, the number of unscheduled medical visits and/or readmissions to the hospital.
Nifedipine is more traditionally used and well-validated by current medical literature. However, enalapril's mechanism of action is better suited to...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of any hypertensive disorder of pregnancy/postpartum period or chronic hypertension
- • provider wanting to initiate antihypertensive in the postpartum period
- • the patient is not currently on \>1 antihypertensive
- • plans to receive postpartum care at the hospital or affiliated clinic
- Exclusion Criteria:
- • sustained pulse \<60 or \>120 BPM over four hours
- • allergy to any of the antihypertensives
- • creatinine greater than or equal to 1.5
- • strict contraindication to any of the antihypertensives
- • history of failed treatment with any of the antihypertensives
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Thomas McElrath, MD, PhD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials